Cytomegalovirus colitis complicating inflammatory bowel disease

American Journal of Gastroenterology

Volumn 101, Issue 12, 2006, Pages 2857-2865

  Kandiel, Ahmed ^a   Lashner, Bret ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; GANCICLOVIR; MONOCLONAL ANTIBODY; STEROID; VALGANCICLOVIR; VIRUS ANTIGEN;

ARTICLE; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; COLITIS; COLON BIOPSY; COLON RESECTION; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC PROCEDURE; ENTERITIS; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; INFECTION RISK; METABOLIC DISORDER; NEPHROTOXICITY; PREVALENCE; PRIORITY JOURNAL; REMISSION; SEROLOGY; VIRUS CULTURE;

COLITIS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 33845459588     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00869.x     Document Type: Article

References (62)

1. Papadakis KA, Tung JK, Binder SW, et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001;96:2137-42.
2. Rowshani AT, Bemelman FJ, van Leeuwen EM, et al. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. Transplantation 2005;79:381-6.
3. Galiatsatos P, Shrier I, Lamoureux E, et al. Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci 2005;50:609-16.
4. Pereyra F, Rubin RH. Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients. Curr Opin Infect Dis 2004;17:357-61.
5. Tanaka K, Numazaki K, Tsutsumi H. Human cytomegalovirus genetic variability in strains isolated from Japanese children during 1983-2003. J Med Virol 2005;76:356-60.
6. Ahumada-Ruiz S, Taylor-Castillo L, Visona K, et al. Determination of human cytomegalovirus genetic diversity in different patient populations in Costa Rica. Rev Inst Med Trop Sao Paulo 2004;46:87-92.
7. Aquino VH, Figueiredo LT. High prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype. J Med Virol 2000;61:138-42.
8. Froberg MK. Review: CMV escapes! Ann Clin Lab Sci 2004;34:123-30.
9. Hengel H, Brune W, Koszinowski UH. Immune evasion by cytomegalovirus - survival strategies of a highly adapted opportunist. Trends Microbiol 1998;6:190-7.
10. Michelson S. Human cytomegalovirus escape from immune detection. Intervirology 1999;42:301-7.
11. Harkins L, Volk AL, Samanta M, et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002;360:1557-63.
12. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 2001;48:526-35.
13. de la Hoz RE, Stephens G, Sherlock C. Diagnosis and treatment approaches of CMV infections in adult patients. J Clin Virol 2002;25(suppl 2):S1-12.
14. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002;34:1094-7.
15. Cottone M, Pietrosi G, Martorana G, et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001;96:773-5.
16. Streetz KL, Buhr T, Wedemeyer H, et al. Acute CMV-colitis in a patient with a history of ulcerative colitis. Scand J Gastroenterol 2003;38:119-22.
17. Kishore J, Ghoshal U, Ghoshal UC, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: Prevalence, clinical significance and outcome. J Med Microbiol 2004;53:1155-60.
18. Criscuoli V, Casa A, Orlando A, et al. Severe acute colitis associated with CMV: A prevalence study. Dig Liver Dis 2004;36:818-20.
19. Beaugerie L, Cywiner-Golenzer C, Monfort L, et al. Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:423-9.
20. Cotte L, Drouet E, Bissuel F, et al. Diagnostic value of amplification of human cytomegalovirus DNA from gastrointestinal biopsies from human immunodeficiency virus-infected patients. J Clin Microbiol 1993;31:2066-9.
21. Chemaly RF, Yen-Lieberman B, Castilla EA, et al. Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J Clin Microbiol 2004;42:2168-72.
22. Kambham N, Vij R, Cartwright CA, et al. Cytomegalovirus infection in steroid-refractory ulcerative colitis: A case-control study. Am J Surg Pathol 2004;28:365-73.
23. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002;15:680-715.
24. Rawlinson WD. Broadsheet number 50: Diagnosis of human cytomegalovirus infection and disease. Pathology 1999;31:109-15.
25. Meyers JD, Ljungman P, Fisher LD. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: Importance of cytomegalovirus viremia. J Infect Dis 1990;162:373-80.
26. Boivin G, Handfield J, Toma E, et al. Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects. J Clin Microbiol 1998;36:2509-13.
27. Lazzarotto T, Dal Monte P, Landini MP. Recent advances in the diagnosis of cytomegalovirus infection. Ann Biol Clin (Paris) 1996;54:259-65.
28. Caliendo AM, Yen-Lieberman B, Baptista J, et al. Comparison of molecular tests for detection and quantification of cell-associated cytomegalovirus DNA. J Clin Microbiol 2003;41:3509-13.
29. Razonable RR, Brown RA, Wilson J, et al. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation 2002;73:968-73.
30. Michaelides A, Liolios L, Glare EM, et al. Increased human cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes after lung transplantation correlates with HCMV pneumonitis. Transplantation 2001;72:141-7.
31. Griffiths PD, Cope AV, Hassan-Walker AF, et al. Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation. Transpl Infect Dis 1999;1:179-86.
32. Stagno S, Reynolds DW, Tsiantos A, et al. Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections. J Infect Dis 1975;132:568-77.
33. Chemaly RF, Yen-Lieberman B, Chapman J, et al. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients. Am J Transplant 2005;5:544-8.
34. Tanabe K, Tokumoto T, Ishikawa N, et al. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation 1997;64:1721-5.
35. Schmidt CA, Oettle H, Peng R, et al. Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation. Transplantation 1995;59:1133-8.
36. Caliendo AM, Schuurman R, Yen-Lieberman B, et al. Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J Clin Microbiol 2001;39:1334-8.
37. Martin-Davila P, Fortun J, Gutierrez C, et al. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: An intent to find the optimal cut-off value. J Clin Virol 2005;33:138-44.
38. Kalpoe JS, Kroes AC, de Jong MD, et al. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. J Clin Microbiol 2004;42:1498-504.
39. Hadaya K, Wunderli W, Deffernez C, et al. Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay. J Clin Microbiol 2003;41:3757-64.
40. Humar A, Gregson D, Caliendo AM, et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 1999;68:1305-11.
41. Pfau P, Kochman ML, Furth EE, et al. Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naive patient. Am J Gastroenterol 2001;96:895-9.
42. Whitley RJ, Jacobson MA, Friedberg DN, et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: Recommendations of an international panel. International AIDS Society, USA. Arch Intern Med 1998;158:957-69.
43. Ginsburg CH, Dambrauskas JT, Ault KA, et al. Impaired natural killer cell activity in patients with inflammatory bowel disease: Evidence for a qualitative defect. Gastroenterology 1983;85:846-51.
44. Hofkin GA, Ting CD. Case report: Recurrence of chronic ulcerative colitis induced by intercurrent cytomegalic virus infection. Md Med J 1995;44:1047-8.
45. Orvar K, Murray J, Carmen G, et al. Cytomegalovirus infection associated with onset of inflammatory bowel disease. Dig Dis Sci 1993;38:2307-10.
46. Iwamoto GK, Monick MM, Clark BD, et al. Modulation of interleukin 1 beta gene expression by the immediate early genes of human cytomegalovirus. J Clin Invest 1990;85:1853-7.
47. van Dorp WT, Jonges E, Bruggeman CA, et al. Direct induction of MHC class I, but not class II, expression on endothelial cells by cytomegalovirus infection. Transplantation 1989;48:469-72.
48. Hommes DW, Sterringa G, van Deventer SJ, et al. The pathogenicity of cytomegalovirus in inflammatory bowel disease: A systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis 2004;10:245-50.
49. Rahbar A, Bostrom L, Lagerstedt U, et al. Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases. Inflamm Bowel Dis 2003;9:154-61.
50. Soderberg-Naucler C, Fish KN, Nelson JA. Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus- permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest 1997;100:3154-63.
51. Maconi G, Colombo E, Zerbi P, et al. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis 2005;37:418-23.
52. Alcala MJ, Casellas F, Pallares J, et al. Infection by cytomegalovirus in patients with ulcerative colitis requiring colonic resection. Med Clin (Barc) 2000;114:201-4.
53. Kaufman HS, Kahn AC, Iacobuzio-Donahue C, et al. Cytomegaloviral enterocolitis: Clinical associations and outcome. Dis Colon Rectum 1999;42:24-30.
54. Eyre-Brook IA, Dundas S. Incidence and clinical significance of colonic cytomegalovirus infection in idiopathic inflammatory bowel disease requiring colectomy. Gut 1986;27:1419-25.
55. Swarbrick ET, Kingham JG, Price HL, et al. Chlamydia, cytomegalovirus, and Yersinia in inflammatory bowel disease. Lancet 1979;2:11-2.
56. Cooper HS, Raffensperger EC, Jonas L, et al. Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection. Gastroenterology 1977;72:1253-6.
57. Vega R, Bertran X, Menacho M, et al. Cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol 1999;94:1053-6.
58. Wakefield AJ, Fox JD, Sawyerr AM, et al. Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol 1992;38:183-90.
59. Wada Y, Matsui T, Matake H, et al. Intractable ulcerative colitis caused by cytomegalovirus infection: A prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum 2003;46(10 suppl):S59-65.
60. Weber B, Fall EM, Berger A, et al. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens. J Clin Virol 1999;14:173-81.
61. Weber B, Berger A, Rabenau H. Human cytomegalovirus infection: Diagnostic potential of recombinant antigens for cytomegalovirus antibody detection. J Virol Methods 2001;96:157-70.
62. Mazzulli T, Drew LW, Yen-Lieberman B, et al. Multicenter comparison of the digene hybrid capture CMV DNA assay (version 2.0), the pp65 antigenemia assay, and cell culture for detection of cytomegalovirus viremia. J Clin Microbiol 1999;37:958-63.